Last week
266 cos reported results
232 cos reported results ex-banks & financials
Sales down 10% yoy but jumped 40% qoq
Ebidta up 30% yoy, up 67% qoq
Which cos reported 20% growth in sales, ebidta & pat?
Clearly impressed with ICICI Securities, PI Ind, Laurus, APL Apollo Tubes
Some smaller names like Bajaj Healthcare, Kopran did vv well
| CoName | Sales YoY% | EBIDTA Growth YoY % | PAT Growth YoY% |
| P I Industries | 27.6 | 46 | 76.6 |
| Laurus Labs | 59.9 | 171 | 328.4 |
| ICICI Securities | 63.2 | 95 | 105.9 |
| APL Apollo Tubes | 33.7 | 135 | 67.1 |
| Angel Broking | 60 | 208 | 191.1 |
| Balaji Amines | 24.3 | 65 | 45.6 |
| L T Foods | 24.4 | 46 | 71 |
| Bajaj Healthcare | 105.5 | 261 | 521 |
| Apollo Pipes | 27.8 | 59 | 63.5 |
| Kopran | 35.6 | 99 | 193.3 |
| CoName | TTM P/E | RoCE% |
| P I Industries | 56 | 22.5 |
| Laurus Labs | 28.6 | 13.6 |
| ICICI Securities | 19.6 | 38.5 |
| APL Apollo Tubes | 32.7 | 19.4 |
| Angel Broking | 35 | 12.9 |
| Balaji Amines | 20.5 | 17.6 |
| L T Foods | 6.8 | 13 |
| Bajaj Healthcare | 13.6 | 20.8 |
| Apollo Pipes | 24.7 | 11.9 |
| Kopran | 13.3 | 12.8 |
Any turnaround cos last week where cos reported profit from loss?
| Co Name | M-cap Rs Cr | PAT 2QFY21 | PAT 1QFY21 | PAT 2QFY20 |
| Orient Cement | 1328 | 35 | 26 | -8 |
| Sharda Cropchem | 2475 | 19 | 28 | -6 |
| Aegis Logistics | 7143 | 57 | 30 | -41 |
| Intellect Design | 3165 | 59 | 43 | -17 |
| GE Shipping Co | 3309 | 225 | 468 | -19 |
| Co Name | Sales 2QFY21 | Sales 1QFY21 | Sales 2QFY20 |
| Orient Cement | 478 | 410 | 515 |
| Sharda Cropchem | 425 | 389 | 324 |
| Aegis Logistics | 650 | 636 | 1818 |
| Intellect Design | 372 | 346 | 327 |
| GE Shipping Co | 775 | 1068 | 818 |
| Co Name | TTM P/E | TTM P/B | RoCE% |
| Orient Cement | 13.4 | 1.1 | 10.9 |
| Sharda Cropchem | 12.7 | 1.7 | 18.3 |
| Aegis Logistics | 41.8 | 4.1 | 12.3 |
| Intellect Design | 24.1 | 2.7 | 3.1 |
| GE Shipping Co | 4.4 | 0.5 | 4.2 |
A look at pharma sector – cos reporting results last week
GOOD: Laurus, Solara, Thyrocare, Bajaj Healthcare, Kopran
Weak: MNCs (GSK Pharma, Sanofi), Suven Pharma
| CoName | Sales YoY% | EBIDTA Growth YoY | PAT Growth YoY% |
| Glaxosmi. Pharma | -0.3 | 6 | -84.8 |
| Sanofi India | -11.9 | 10 | 5 |
| Laurus Labs | 59.9 | 171 | 328.4 |
| Suven Pharma | -13 | -22 | -20.3 |
| Strides Pharma | 11 | 10 | -43.3 |
| Thyrocare Tech. | 31.8 | 19 | 22.8 |
| Poly Medicure | 14.8 | 35 | 23.3 |
| Solara Active | 13.2 | 44 | 96 |
| Bajaj Healthcare | 105.5 | 261 | 521 |
| Suven Life Scie. | 546 | -17 | -21 |
| RPG LifeScience. | -1.4 | 17 | 14.1 |
| Kopran | 35.6 | 99 | 193.3 |
| CoName | TTM P/E | TTM P/B |
| Glaxosmi. Pharma | 67.4 | 18.7 |
| Sanofi India | 35.7 | 6.9 |
| Laurus Labs | 28.6 | 7.8 |
| Suven Pharma | 26.9 | 7.9 |
| Strides Pharma | 35.1 | 2.3 |
| Thyrocare Tech. | 88.5 | 14.4 |
| Poly Medicure | 38.8 | 8.6 |
| Solara Active | 25.8 | 2.8 |
| Bajaj Healthcare | 13.6 | 4.3 |
| Suven Life Scie. | 0 | 5 |
| RPG LifeScience. | 17.2 | 3.3 |
| Kopran | 13.3 | 2.6 |
Good cos at reasonable valuations?
M-cap > 500 cr
Excluded banks & financials
P/E< 20
RoCE> 10%
ICICI Sec – great franchise at reasonable valuatins
LT Food – great results but watch for consistency
Strong and cheap: KPR Mills
Dark Horse: Kopran, Bajaj Healthcare
UPL: cheap, strong results but do u trust?
APL Apollo, Solara & Laurus expensive on TTM basis
| CoName | M-cap Rs Cr | TTM P/E | RoCE% | Sales YoY% | EBIDTA Growth YoY | PAT Growth YoY% |
| Bajaj Healthcare | 740 | 13.6 | 20.8 | 105.5 | 261 | 521 |
| ICICI Securities | 14940 | 19.6 | 38.5 | 63.2 | 95 | 105.9 |
| Kopran | 564 | 13.3 | 12.8 | 35.6 | 99 | 193.3 |
| L T Foods | 1702 | 6.8 | 13 | 24.4 | 46 | 71 |
| K P R Mill Ltd | 5072 | 14.6 | 19.6 | 16.6 | 10 | 3.1 |
| UPL | 34623 | 15.2 | 10.5 | 14.4 | 15 | 178.9 |
Cos reporting weak results but trading v cheap
GE Shipping: 0.5 p/b, 5x pe
sales were down yoy and qoq
Tata Chem: 0.6 p/b, 15x ttm pe
sales were down 6%, ebidta down 30%
JK Paper: p/b 0.7, p/e 5.8x
sales were down 20%, ebidta down 50%
